• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌免疫浸润中的可变剪接事件。

Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma.

机构信息

Department of Clinical Laboratory, Wenzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Wenzhou, Zhejiang, China (mainland).

Department of Respiratory and Critical Care Medicine, Wenzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Wenzhou, Zhejiang, China (mainland).

出版信息

Med Sci Monit. 2021 Dec 5;27:e934491. doi: 10.12659/MSM.934491.

DOI:10.12659/MSM.934491
PMID:34864813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8656114/
Abstract

BACKGROUND The exact mechanisms of lung adenocarcinoma (LUAD) etiology and pathogenesis remain unclear. MATERIAL AND METHODS In this study, we evaluated alternative splicing (AS) events in LUAD. We separately analyzed LUAD data from The Cancer Genome Atlas (TCGA) database and AS-related feature lists from SpliceSeq to develop risk models for AS events and further validated risk models for AS events. The association between immune-related features and the risk model of AS events was evaluated. RESULTS We found that exon skip (ES) and mutually exclusive exons (ME) exhibited the most and least AS events, respectively. The risk score and stage of LUAD patients were strongly associated with prognosis and were independent influences on the prognosis of LUAD. The pathological stage (stage, T, N) and risk model were incorporated to construct a column line graph with better predictive ability. Risk models were associated with tumor microenvironment, and higher risk score values were associated with higher M2 macrophage content and lower M0 macrophage and helper T lymphocyte content. The correlation between core genes and immunity was further assessed by analyzing differentially-expressed genes between risk models. These results suggest an association between the level of risk for AS events and the density of immune cell infiltration. CONCLUSIONS Our findings suggest a clear association between AS risk model and patient prognosis, and was performed to confirm the biological relationship between AS and immunity.

摘要

背景

肺腺癌(LUAD)的发病机制仍不清楚。

材料和方法

本研究评估了 LUAD 的可变剪接(AS)事件。我们分别分析了来自癌症基因组图谱(TCGA)数据库的 LUAD 数据和 SpliceSeq 的 AS 相关特征列表,以开发 AS 事件的风险模型,并进一步验证了 AS 事件的风险模型。评估了免疫相关特征与 AS 事件风险模型之间的关系。

结果

我们发现外显子跳跃(ES)和互斥外显子(ME)分别具有最多和最少的 AS 事件。LUAD 患者的风险评分和分期与预后密切相关,是 LUAD 预后的独立影响因素。将病理分期(分期、T、N)和风险模型结合起来构建列线图,具有更好的预测能力。风险模型与肿瘤微环境相关,较高的风险评分值与较高的 M2 巨噬细胞含量和较低的 M0 巨噬细胞和辅助 T 淋巴细胞含量相关。通过分析风险模型之间差异表达基因,进一步评估了核心基因与免疫之间的相关性。这些结果表明 AS 事件风险模型与免疫细胞浸润密度之间存在关联。

结论

我们的研究结果表明,AS 风险模型与患者预后之间存在明显的关联,并对 AS 与免疫之间的生物学关系进行了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/852d528ea475/medscimonit-27-e934491-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/c48c6b330a83/medscimonit-27-e934491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/3bf3bddde286/medscimonit-27-e934491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/f1744e927f81/medscimonit-27-e934491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/189384f8e4ee/medscimonit-27-e934491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/c377763e53cd/medscimonit-27-e934491-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/06a612f91b22/medscimonit-27-e934491-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/e4686fb9a73b/medscimonit-27-e934491-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/5bf673fda85d/medscimonit-27-e934491-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/852d528ea475/medscimonit-27-e934491-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/c48c6b330a83/medscimonit-27-e934491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/3bf3bddde286/medscimonit-27-e934491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/f1744e927f81/medscimonit-27-e934491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/189384f8e4ee/medscimonit-27-e934491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/c377763e53cd/medscimonit-27-e934491-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/06a612f91b22/medscimonit-27-e934491-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/e4686fb9a73b/medscimonit-27-e934491-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/5bf673fda85d/medscimonit-27-e934491-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8656114/852d528ea475/medscimonit-27-e934491-g009.jpg

相似文献

1
Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma.肺腺癌免疫浸润中的可变剪接事件。
Med Sci Monit. 2021 Dec 5;27:e934491. doi: 10.12659/MSM.934491.
2
The pattern of alternative splicing in lung adenocarcinoma shows novel events correlated with tumorigenesis and immune microenvironment.肺腺癌中可变剪接的模式显示出与肿瘤发生和免疫微环境相关的新事件。
BMC Pulm Med. 2021 Dec 6;21(1):400. doi: 10.1186/s12890-021-01776-0.
3
Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer.结直肠癌肿瘤免疫浸润中的可变剪接事件
Front Oncol. 2021 Apr 29;11:583547. doi: 10.3389/fonc.2021.583547. eCollection 2021.
4
Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.TTC21A 在肺腺癌中的高表达预示着良好的预后和高水平的免疫浸润。
Int Immunopharmacol. 2020 Jan;78:106077. doi: 10.1016/j.intimp.2019.106077. Epub 2019 Dec 5.
5
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.新型基质/免疫评分相关 P2RY12 在肺腺癌微环境中的预后价值及免疫浸润分析。
Int Immunopharmacol. 2021 Sep;98:107734. doi: 10.1016/j.intimp.2021.107734. Epub 2021 Jun 25.
6
Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.鉴定肺腺癌中关键的铁死亡调控因子,RRM2 通过抑制铁死亡死亡促进肿瘤免疫浸润。
Clin Immunol. 2021 Nov;232:108872. doi: 10.1016/j.clim.2021.108872. Epub 2021 Oct 11.
7
A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma.一种利用可变剪接事件和免疫微环境特征的肺腺癌预测模型。
Front Oncol. 2021 Dec 22;11:778637. doi: 10.3389/fonc.2021.778637. eCollection 2021.
8
Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.肿瘤突变负荷与免疫浸润联合用于肺腺癌的预后评估。
Int Immunopharmacol. 2021 Sep;98:107807. doi: 10.1016/j.intimp.2021.107807. Epub 2021 Jun 25.
9
A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.一个与免疫密切相关的七基因标志物被鉴定出来,可用于预测肺腺癌的生存。
Med Sci Monit. 2020 Jul 2;26:e924269. doi: 10.12659/MSM.924269.
10
Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.基于肺腺癌差异表达免疫基因的优化预后模型构建。
BMC Cancer. 2021 Mar 1;21(1):213. doi: 10.1186/s12885-021-07911-8.

引用本文的文献

1
Identification of pancreatic adenocarcinoma immune subtype associated with tumor neoantigen from aberrant alternative splicing.鉴定与异常可变剪接产生的肿瘤新抗原相关的胰腺腺癌免疫亚型
J Gastrointest Oncol. 2024 Jun 30;15(3):1179-1197. doi: 10.21037/jgo-24-340. Epub 2024 Jun 27.

本文引用的文献

1
Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.肺腺癌全基因组可变剪接分析及潜在药物研发
Front Genet. 2021 Oct 19;12:767259. doi: 10.3389/fgene.2021.767259. eCollection 2021.
2
Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer.用于不可切除胰腺癌患者最佳治疗的简单预后标志物。
Medicine (Baltimore). 2021 Oct 29;100(43):e27591. doi: 10.1097/MD.0000000000027591.
3
A systematic review of proteomic biomarkers in oral squamous cell cancer.
口腔鳞状细胞癌中蛋白质组学标志物的系统评价。
World J Surg Oncol. 2021 Oct 28;19(1):315. doi: 10.1186/s12957-021-02423-y.
4
Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer.结直肠癌肿瘤免疫浸润中的可变剪接事件
Front Oncol. 2021 Apr 29;11:583547. doi: 10.3389/fonc.2021.583547. eCollection 2021.
5
The Role of CD276 in Cancers.CD276在癌症中的作用。
Front Oncol. 2021 Mar 26;11:654684. doi: 10.3389/fonc.2021.654684. eCollection 2021.
6
Hypoxia-associated alternative splicing signature in lung adenocarcinoma.肺腺癌中与缺氧相关的可变剪接特征。
Epigenomics. 2021 Jan;13(1):47-63. doi: 10.2217/epi-2020-0399. Epub 2020 Dec 18.
7
A genome-wide association study implicates that the gene is associated with diabetic maculopathy with decreased visual acuity.一项全基因组关联研究表明,该基因与视力下降的糖尿病性黄斑病变有关。
Ophthalmic Genet. 2019 Jun;40(3):252-258. doi: 10.1080/13816810.2019.1633549. Epub 2019 Jul 2.
8
Ttc39c is upregulated during skeletal muscle atrophy and modulates ERK1/2 MAP kinase and hedgehog signaling.Ttc39c 在骨骼肌萎缩过程中上调,并调节 ERK1/2 MAP 激酶和 hedgehog 信号通路。
J Cell Physiol. 2019 Dec;234(12):23807-23824. doi: 10.1002/jcp.28950. Epub 2019 Jun 12.
9
Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy.非小细胞肺癌的生物标志物:个体化靶向治疗的观点。
Anticancer Agents Med Chem. 2018;18(15):2070-2077. doi: 10.2174/1871520618666180827102101.
10
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression.肺癌进展过程中 FBP1 诱导的糖酵解抑制导致自然杀伤细胞功能障碍。
Cell Metab. 2018 Aug 7;28(2):243-255.e5. doi: 10.1016/j.cmet.2018.06.021. Epub 2018 Jul 19.